147 related articles for article (PubMed ID: 37187635)
1. The Optimal Dosing Regimen of Super Bioavailable Itraconazole in Obesity: An Experimental Rat Model Study.
Jain GK; Chitnis KR; Singhal P; Mahadkar N; Dhoot D; Barkate H
Cureus; 2023 Apr; 15(4):e37462. PubMed ID: 37187635
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis.
Dhoot D; Jain GK; Manjhi M; Kesharwani P; Mahadkar N; Barkate H
Drugs Context; 2023; 12():. PubMed ID: 36660014
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial.
Shenoy MM; De A; Shah B; Das A; Saraswat A; Lahiri K; Yadav S; Sarda A; Chakraborty D; J D; Kamat S; Doshi Y; Gonsalves N; Choudhary A; Dhoot D; Mahadkar N; Bhushan S; Gadkari R; Barkate H
Drug Des Devel Ther; 2023; 17():2899-2908. PubMed ID: 37766823
[TBL] [Abstract][Full Text] [Related]
4. Clinical Use of Super-Bioavailable Itraconazole for the Management of Dermatophytosis: Consensus Statement by Dermatologists from India via the Modified Delphi Technique.
Saraswat A; Dogra S; Shenoy M; Verma S; K S; Ghate S; Ganjoo A; Aurangabadkar S; Tiwari A; Poojary S; Inamdar A; Majid I; Girdhar M; Shah B; Varma S; Ramamoorthy R; Dhoot D; Barkate H
Dermatology; 2024 May; ():1-13. PubMed ID: 38697027
[TBL] [Abstract][Full Text] [Related]
5. Open-Label Crossover Oral Bioequivalence Pharmacokinetics Comparison for a 3-Day Loading Dose Regimen and 15-Day Steady-State Administration of SUBA-Itraconazole and Conventional Itraconazole Capsules in Healthy Adults.
Thompson GR; Lewis P; Mudge S; Patterson TF; Burnett BP
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32457106
[TBL] [Abstract][Full Text] [Related]
6. Comparative Efficacy and Safety of Super-Bioavailable Itraconazole-130 mg Once Daily in Obese and Non-Obese Patients of Glabrous Tinea.
Shenoy M; De A; Shah B; Das A; Saraswat A; Lahiri K; Dhoot D
Indian Dermatol Online J; 2023; 14(6):839-843. PubMed ID: 38099030
[TBL] [Abstract][Full Text] [Related]
7. Comparative Efficacy of Super Bioavailable Itraconazole Capsules 50 mg vs 65 mg Twice Daily in the Management of Glabrous Tinea.
Shah B; Mistry D; Jairam D; Kansara K; Pandya R; Vasani P; Dhoot D; Mahadkar N; Bhushan S; Barkate H
Infect Drug Resist; 2023; 16():2409-2416. PubMed ID: 37125212
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus.
Oakley KL; Morrissey G; Denning DW
Antimicrob Agents Chemother; 1997 Jul; 41(7):1504-7. PubMed ID: 9210674
[TBL] [Abstract][Full Text] [Related]
9. Single dose and multiple dose studies of itraconazole nanoparticles.
Vaughn JM; McConville JT; Burgess D; Peters JI; Johnston KP; Talbert RL; Williams RO
Eur J Pharm Biopharm; 2006 Jun; 63(2):95-102. PubMed ID: 16516450
[TBL] [Abstract][Full Text] [Related]
10. Influence of grapefruit juice on the systemic availability of itraconazole oral solution in healthy adult volunteers.
Gubbins PO; McConnell SA; Gurley BJ; Fincher TK; Franks AM; Williams DK; Penzak SR; Saccente M
Pharmacotherapy; 2004 Apr; 24(4):460-7. PubMed ID: 15098799
[TBL] [Abstract][Full Text] [Related]
11. IADVL SIG Recalcitrant Dermatophytosis Position Statement on Super Bioavailable Itraconazole.
Patel NH; Sardana K; Shenoy MM; Rengasamy M; Khurana A; Ghate S; Venkata CK; Marfatiya Y; Bhunia D; Jayaraman J; Das A; Jain AK
Indian Dermatol Online J; 2024; 15(1):1-7. PubMed ID: 38283009
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intravenous itraconazole against invasive pulmonary aspergillosis in neutropenic mice.
Tansho S; Abe S; Ishibashi H; Torii S; Otani H; Ono Y; Yamaguchi H
J Infect Chemother; 2006 Dec; 12(6):355-62. PubMed ID: 17235640
[TBL] [Abstract][Full Text] [Related]
13. Development of PLGA-based itraconazole injectable nanospheres for sustained release.
Bian X; Liang S; John J; Hsiao CH; Wei X; Liang D; Xie H
Int J Nanomedicine; 2013; 8():4521-31. PubMed ID: 24311942
[TBL] [Abstract][Full Text] [Related]
14. Semi-micro column HPLC of triazolam in rat plasma and brain microdialysate and its application to drug interaction study with itraconazole.
Nakashima K; Yamamoto K; Al-Dirbashi OY; Kaddoumi A; Nakashima MN
J Pharm Biomed Anal; 2003 Jan; 30(6):1809-16. PubMed ID: 12485722
[TBL] [Abstract][Full Text] [Related]
15. Distribution of an antifungal drug, itraconazole, in pathological and non-pathological tissues.
Seishima M; Oyama Z; Oda M; Ishigo S
Eur J Dermatol; 2004; 14(1):24-7. PubMed ID: 14965791
[TBL] [Abstract][Full Text] [Related]
16. Preparation of Topical Itraconazole with Enhanced Skin/Nail Permeability and In Vivo Antifungal Efficacy against Superficial Mycosis.
Subedi L; Song SY; Jha SK; Lee SH; Pangeni R; Koo KT; Kim BJ; Cho SS; Park JW
Pharmaceutics; 2021 Apr; 13(5):. PubMed ID: 33925457
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and biodistribution of itraconazole in rats and mice following intravenous administration in a novel liposome formulation.
Tang J; Wei H; Liu H; Ji H; Dong D; Zhu D; Wu L
Drug Deliv; 2010 May; 17(4):223-30. PubMed ID: 20210560
[TBL] [Abstract][Full Text] [Related]
18. Does current cefazolin dosing achieve adequate tissue and blood concentrations in obese women undergoing cesarean section?
Kram JJF; Greer DM; Cabrera O; Burlage R; Forgie MM; Siddiqui DS
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():334-341. PubMed ID: 28122314
[TBL] [Abstract][Full Text] [Related]
19. Lack of Pharmacokinetic Basis of Weight-Based Dosing and Intra-Operative Re-Dosing with Cefazolin Surgical Prophylaxis in Obese Patients: Implications for Antibiotic Stewardship.
Blum S; Cunha CB; Cunha BA
Surg Infect (Larchmt); 2019 Sep; 20(6):439-443. PubMed ID: 31112072
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
